Glaukos Corporation
GKOS
Rangering i aksjer
#2023
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Aksjekurs
$174.03
Markedsverdi
$10.26B
Endring (1 dag)
4.34%
Endring (1 år)
118.99%
Land
US
Handel Glaukos Corporation (GKOS)
Kategori
Healthcare
Historikk for aksjesplitt for Glaukos Corporation (GKOS)
Aksjen Glaukos Corporation (symbol: GKOS) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én GKOS-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 GKOS-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én GKOS-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 GKOS-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 2 | x4 |
US
|
|
| 0 | - |
DE
|
